Ceftazidime/Avibactam Monotherapy Versus Other Antibiotics: Where Do We Stand?

The global rise of multi-drug resistant (MDR) pathogens, including the widespread resistance to beta-lactams through the production of β-lactamases, like extended spectrum β-lactamases (ESBLs), has led to the increasing use of last-line antibiotics such as carbapenems. Subsequently, the worldwide em...

Descripció completa

Dades bibliogràfiques

Autors principals:	Georgios Vougiouklakis, Constantinos Tsioutis, Nayia Vasileiadi, Konstantinos Alexakis, Nikolaos Spernovasilis, Aris P. Agouridis
Format:	Artigo
Idioma:	Inglês
Publicat:	MDPI AG 2025-11-01
Col·lecció:	Pathogens
Matèries:	Gram-negative multidrug resistance ceftazidime/avibactam cephalosporins carbapenems b-lactamase
Accés en línia:	https://www.mdpi.com/2076-0817/14/11/1119
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!